Literature DB >> 19478405

Evidence for the role of osteocytes in the initiation of targeted remodeling.

Terhi J Heino1, Kosaku Kurata, Hidehiko Higaki, H Kalervo Väänänen.   

Abstract

Microdamage in bone contributes to fractures and acts as a stimulus for bone remodeling. Osteocytes are the most abundant cells in bone, and their death by microdamage has been suggested to be the major event leading in the initiation of osteoclastic bone resorption. Even though there is increasing evidence that osteocyte density, microcracks and targeted remodeling are related, there still exist several questions. For example, how osteoclasts are targeted to the specific site of microdamage for repair. It has been proposed that apoptotic osteocytes could secrete a specific signal to target osteoclasts. The other question is the nature of this signal. To elucidate the role of microdamage-induced osteocyte cell death in the initiation of targeted remodelling, this paper discusses the potential use of an in vitro model, in which osteocytes can be three-dimensionally cultured and locally damaged. Furthermore, the method enables one to study the osteocyte-derived soluble interactions with bone marrow cells. It was demonstrated that damaged osteocytes locally affect osteoclast precursors by secreting osteoclastogenic factors, and thus can have a role in the initiation of resorption in bone remodelling. This strongly supports the idea that damage to osteocyte cellular network has the potential to stimulate osteoclastic proliferation and therefore the activation of Basic Multicellular Units (BMUs).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478405     DOI: 10.3233/THC-2009-0534

Source DB:  PubMed          Journal:  Technol Health Care        ISSN: 0928-7329            Impact factor:   1.285


  15 in total

1.  Urinary levels of cross-linked N-terminal telopeptide of type I collagen and nutritional status in Japanese professional baseball players.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Kazuhiro Uenishi; Hiromi Ishida; Yoshihiro Sato; Hideo Matsumoto
Journal:  J Bone Miner Metab       Date:  2010-02-18       Impact factor: 2.626

2.  Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defects.

Authors:  Stephen E Harris; Mary MacDougall; Diane Horn; Kathleen Woodruff; Stephanie N Zimmer; Vivienne I Rebel; Roberto Fajardo; Jian Q Feng; Jelica Gluhak-Heinrich; Marie A Harris; Sherry Abboud Werner
Journal:  Bone       Date:  2011-09-20       Impact factor: 4.398

3.  Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.

Authors:  Ehab Azab; Kevin Brown Chandler; Yuhei Uda; Ningyuan Sun; Amira Hussein; Raghad Shuwaikan; Veronica Lu; Catherine E Costello; Mark E McComb; Paola Divieti Pajevic
Journal:  FASEB J       Date:  2020-06-18       Impact factor: 5.191

Review 4.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

Review 5.  The effect of antiresorptives on bone quality.

Authors:  Robert R Recker; Laura Armas
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

Review 6.  Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2014-07-17       Impact factor: 4.507

7.  Activation of intracellular calcium signaling in osteoblasts colocalizes with the formation of post-yield diffuse microdamage in bone matrix.

Authors:  Hyungjin Jung; Ozan Akkus
Journal:  Bonekey Rep       Date:  2016-03-02

Review 8.  Is interaction between age-dependent decline in mechanical stimulation and osteocyte-estrogen receptor levels the culprit for postmenopausal-impaired bone formation?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

Review 9.  The osteocyte as a therapeutic target in the treatment of osteoporosis.

Authors:  Gaël Y Rochefort
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-06       Impact factor: 5.346

10.  Allogeneic yet major histocompatibility complex-matched bone marrow transplantation in mice results in an impairment of osteoblasts and a significantly reduced trabecular bone.

Authors:  Anja Osterberg; Robby Engelmann; Brigitte Müller-Hilke
Journal:  J Bone Miner Metab       Date:  2017-08-01       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.